info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0083246-01
Couldn't load pickup availability
Brivanib (BMS-540215) is an ATP-competitive inhibitor against VEGFR2 with an IC50 of 25 nM, and has moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β[1].
[649735-46-6]
C19H19FN4O3
370.38
FC1=C(OC2=NC=NN3C2=C(C(OC[C@H](O)C)=C3)C)C=CC4=C1C=C(C)N4
Autophagy; VEGFR
VEGFR2/KDR/Flk-1
10mM
99.92
DMSO : ≥ 50 mg/mL
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
H302, H315, H319, H335
Loading...
Total items
Product subtotal
Brivanib is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.